Skip to main content

Cearnal Martin E's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Oct 1, 2021

Accession no.
0001209191-21-058506
Filed
Oct 1, 2021
Trade date
Sep 1-30, 2021
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $6.24K. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cearnal Martin ECIK 0001408500Director, Officer (Sr VP/Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2021Common StockPPurchaseAcquired+105$2.88+$302.4169,569Direct
Sep 2, 2021Common StockPPurchaseAcquired+105$2.88+$302.4169,674Direct
Sep 3, 2021Common StockPPurchaseAcquired+105$2.85+$299.25169,779Direct
Sep 7, 2021Common StockPPurchaseAcquired+105$2.79+$292.95169,884Direct
Sep 8, 2021Common StockPPurchaseAcquired+105$2.89+$303.45169,989Direct
Sep 9, 2021Common StockPPurchaseAcquired+105$2.77+$290.85170,094Direct
Sep 10, 2021Common StockPPurchaseAcquired+105$2.78+$291.9170,199Direct
Sep 13, 2021Common StockPPurchaseAcquired+105$2.96+$310.8170,304Direct
Sep 14, 2021Common StockPPurchaseAcquired+105$3.02+$317.1170,409Direct
Sep 15, 2021Common StockPPurchaseAcquired+105$2.86+$300.3170,514Direct
Sep 16, 2021Common StockPPurchaseAcquired+105$2.91+$305.55170,619Direct
Sep 17, 2021Common StockPPurchaseAcquired+105$2.85+$299.25170,724Direct
Sep 20, 2021Common StockPPurchaseAcquired+105$2.82+$296.1170,829Direct
Sep 21, 2021Common StockPPurchaseAcquired+105$2.81+$295.05170,934Direct
Sep 22, 2021Common StockPPurchaseAcquired+105$2.76+$289.8171,039Direct
Sep 23, 2021Common StockPPurchaseAcquired+105$2.75+$288.75171,144Direct
Sep 24, 2021Common StockPPurchaseAcquired+105$2.74+$287.7171,249Direct
Sep 27, 2021Common StockPPurchaseAcquired+105$2.79+$292.95171,354Direct
Sep 28, 2021Common StockPPurchaseAcquired+105$2.76+$289.8171,459Direct
Sep 29, 2021Common StockPPurchaseAcquired+105$2.82+$296.1171,564Direct
Sep 30, 2021Common StockPPurchaseAcquired+105$2.72+$285.6171,669Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)